Search

Doppler echocardiography was performed on 108 patients 4-15 days after implantation of a Medtronic-Hall, Biocor or Carpentier-Edwards S.A.V. prosthetic aortic valve because of aortic stenosis. Significant correlation was found between the in vitro (maker-declared) and the Doppler-estimated effective prosthetic valve orifice area (r = 0.70, p < 0.01). Doppler-estimated prosthetic valve orifice area, but not transprosthetic blood velocities, discriminated between different sizes of Medtronic-Hall and Biocor valves. The effective orifice area in these valves was 57% of the in vitro area, but in Carpentier-Edwards valves it was only 43%. Transprosthetic blood velocity was inversely related to orifice area in men, but not in women, who also had longer duration of systole and better preservation of systolic left ventricular function. The data suggest that the effective prosthetic valve areas found in patients are significantly smaller than the experimental in vitro areas. Prosthesis size and type, anatomic and hemo-dynamic variables and gender are important in Doppler estimation of effective valve area.

The clinical usefulness of M-mode echocardiography for predicting severe mitral regurgitation (MR) requiring valve replacement was assessed in 16 men and 10 women with mitral valve prolapse (MVP) as sole primary cardiac disorder. From left ventricular (LV) angiography, MR was classified as none to moderate (8 cases, group A) or severe (18 cases, group B). At echocardiography, increased LV end-diastolic and end-systolic and left atrial (LA) dimensions, corrected for body-surface area, distinguished group B from group A, with the best validities for LA and LV end-diastolic values. The mean echocardiographic LV fractional shortening and ejection fraction (EF) and the angiographic EF were similar in both groups. Echocardiographic and angiocardiographic LV EF correlated poorly, the former usually overestimating the latter. LV end-diastolic and mean pulmonary capillary wedge pressures were highest in group B, and the latter correlated with echocardiographic LA size. Mitral valve replacement was subsequently performed on 15 of the 18 group B patients. M-mode echocardiography is a valuable adjuvant to clinical assessment of MVP for predicting MR severity and for time-planning of cardiac catheterization or mitral valve surgery.